(NASDAQ: XOMA) Xoma's forecast annual earnings growth rate of 42.57% is forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 6.97%, and and it is also forecast to beat the US market's average forecast earnings growth rate of 24.23%.
Xoma's earnings in 2023 is $9,793,000.On average, 3 Wall Street analysts forecast XOMA's earnings for 2023 to be -$3,206,230, with the lowest XOMA earnings forecast at -$10,992,790, and the highest XOMA earnings forecast at $6,526,969. On average, 1 Wall Street analyst forecast XOMA's earnings for 2024 to be $13,397,463, with the lowest XOMA earnings forecast at $13,397,463, and the highest XOMA earnings forecast at $13,397,463.
In 2025, XOMA is forecast to generate $29,428,615 in earnings, with the lowest earnings forecast at $29,428,615 and the highest earnings forecast at $29,428,615.